Q3-FY26 · Rajiv Gandhi
The bird flu attack in Kerala has nothing to do with these numbers. Neither does it show a spurt in sales which has caused this profitability.
Hester Biosciences · tone and specificity signals across the available quarters.
Language signals
The bird flu attack in Kerala has nothing to do with these numbers. Neither does it show a spurt in sales which has caused this profitability.
We are here to grow our poultry business as well as the AH business. That's all that we can say.
Our strategic priorities remain clear: to reduce dependence on tender-driven revenues and deepen our presence across commercial and export markets.
The poultry healthcare division delivered a strong performance during the year growing by 41% in Q4 and 21% for the entire financial year.
We have supplied 6.3 cr doses in Q4 for PPR.
This is a base and we want to sustain this.